Raina Jean Cryoskie

Raina Cryoskie supports the procurement mission of W40M Mrco Pacific under the Department of the Army, ensuring the readiness of U.S. military medical capabilities across the Indo-Pacific region. Responsible for managing complex acquisitions of biomedical infrastructure, Cryoskie oversees the procurement of in-vitro diagnostic systems, electromedical equipment, surgical instruments, and clinical laboratory support services. Their work directly enables the operational sustainability of military treatment facilities by securing mission-critical medical technologies that enhance diagnostic accuracy, surgical precision, and point-of-care testing capacity in austere environments. Cryoskie’s portfolio emphasizes high-reliability, FDA-regulated medical devices and laboratory automation systems requiring stringent compliance with military specifications and supply chain resilience standards. Cryoskie maintains longstanding contractual relationships with leading biomedical and diagnostics vendors, including Roche Diagnostics Corporation, BioFire Defense LLC, Siemens Healthcare Diagnostics Inc., Jupiter Logix Inc., and Island Neuro Inc. These partnerships reflect a preference for established industry leaders with proven track records in military-grade medical technology, particularly in molecular diagnostics, automated clinical analyzers, and ruggedized electromedical platforms. The working relationship pattern is characterized by long-term service agreements, performance-based contract structures, and technical collaboration to ensure equipment interoperability with military health information systems. Cryoskie’s contracting approach prioritizes open competition, with 86.4% of awards issued without set-aside restrictions, reflecting the technical complexity and limited vendor base for specialized medical equipment. However, a consistent 13.6% of acquisitions are structured as Total Small Business Set-Asides under FAR 19.5, demonstrating targeted support for qualified small businesses capable of supplying niche diagnostic components or maintenance services. This balance ensures access to innovation while maintaining operational reliability. The procurement focus centers on NAICS 325413 (in-vitro diagnostic substance manufacturing), 811210 (electronic and precision equipment repair and maintenance), and 339112 (surgical and medical instrument manufacturing), with significant activity in clinical laboratory systems and electromedical device sustainment. Cryoskie’s expertise lies in acquiring advanced diagnostic platforms, surgical tooling, and maintenance services critical to force health protection and expeditionary medical readiness.